NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/03/2024
Back to search
Official data from USPTO
CELLGENUITY REGENERATIVE SCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
12/03/2024
Trademark type
Combined
Nice classes
1, 5
Filing date
03/19/2018
Registration date
06/11/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/01/2018
First use in commerce
05/01/2018
Drawing code
3
Owner type
16
Owner location
Grapevine, TX
Examiner
RADEMACHER, APRIL
Current location
Historical data usage
Mark description
The mark consists of the word "CELLGENUITY" with an initial capital letter "C" and a capital letter "G" and the "GENUITY" portion in bold text, above the words "REGENERATIVE SCIENCE" in smaller text, and below a stylized design of connected hexagons and curved lines.
Holders and representatives
Holders
Cellgenuity LLC
Representatives
Carol M. Wilhelm GRAY REED & MCGRAW LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological tissuebloodstem cellsumbilical cords and placentas for scientific and medical research use
Class 5
Biological tissue grafts; biological implantsa vital processed human or animal connective tissue; biological placental tissue intended for subsequent implantation; human allograft tissue; human allograft bone and tissue; natural biomaterials for augmentation of bone and tissue for medical purposes
Publications
History of USPTO decisions and trademark events.
29 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/03/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/03/2024
E815
TEAS SECTION 8 & 15 RECEIVED
06/24/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/07/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/06/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/07/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/07/2019
IUAF
USE AMENDMENT FILED
03/22/2019
EISU
TEAS STATEMENT OF USE RECEIVED
03/22/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/23/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/28/2018
PUBO
PUBLISHED FOR OPPOSITION
08/28/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/08/2018
ALIE
ASSIGNED TO LIE
07/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/04/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
07/04/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/04/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
07/04/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/04/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/30/2018
GNRT
NON-FINAL ACTION E-MAILED
06/30/2018
CNRT
NON-FINAL ACTION WRITTEN
06/30/2018
DOCK
ASSIGNED TO EXAMINER
06/28/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/27/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/24/2018
NWAP
NEW APPLICATION ENTERED
03/22/2018
Continuous trademark protection
Get notified about every new filing that threatens CELLGENUITY REGENERATIVE SCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.